Evaluation of the anti-tumor efficacy of combined nivolumab (anti-PD-L1) and ipilimumab (anti-CTLA-4) therapies in a metastatic OS patient resulted in complete stabilization of life-threatening retrocardiac lesions and progression of bone wounds and pleural metastases [69]. Here, CD274 is linked to neoplasm.